Copy
Previous health care provider updates can be found here

Contents

COVID-19 Updated Guidance



Top

URGENT: Call-out for Community Vaccine Provider Support


TBDHU requires community vaccine provider support at the COVID-19 mass immunization clinic next week (week of January 17). If you have not volunteered in our clinic before and would like to help administer vaccines, please email Hafsa Siddiqui at hafsa.siddiqui@tbdhu.com as soon as possible.


Top

Provincial Eligibility by Age

Eligibility is now determined by date of birth.

Primary Vaccination Series
  • Must be 5 years or older on day of appointment. Note: A three dose series is recommended for all immunocompromised individuals aged 5+.
Booster Dose
  • Most individuals must be age 18 on the day of their appointment (eligible based on birth date) to receive a booster dose.
  • Health care workers or First Nations, Inuit, or Metis individuals must be age 16 on the day of their appointment to receive a booster dose.  A list of eligible health care workers can be found on page 19 of the Third Dose Recommendations guidance.
  • Note: Information on 4th doses for immunocompromised will be available by the end of the week.

Top

Extended Shelf Life for Moderna Spikevax COVID-19 Vaccine


Important Information on the Shelf Life Extension for the SPIKEVAX (elasomeran) COVID-19 Vaccine with Printed Expiry Dates on Vial and Carton Labels - Moderna Biopharma Canada Corporation:

Health Canada has authorized a shelf-life extension, from 7 months to 9 months, for SPIKEVAX / COVID-19 Vaccine Moderna 5 mL vials. This 2-month extension may be retroactively applied to vials that are currently on the market with printed expiry dates between February 2022 and August 2022, as long as the approved storage conditions have been maintained.

You can read more about the extension on the Government of Canada website.

Top

PHO Webinar: Opioid-Related Toxicity Deaths During the COVID-19 Pandemic


Ontario is facing increasing rates of opioid-related toxicity during the COVID-19 pandemic. At the end of 2020, The Ontario Drug Policy Research Network (ODPRN), The Office of the Chief Coroner for Ontario/Ontario Forensic Pathology Service, and Public Health Ontario (PHO) completed a report on patterns of health care utilization among people who experienced a fatal overdose in Ontario during the COVID-19 pandemic. This session will summarize the findings (up to the end of December 2020) from this analysis and discuss implications for planning and practice to reduce overdose and overdose risk. The first presenter will share an overview of the report findings, followed by two presenters that will discuss intervention gaps and opportunities to better support people who use drugs. Participants will have an opportunity to engage in a facilitated question and answer period to discuss findings and application to practices.

Date: Tuesday, Jan 18, 2022
Time: 12:00-1:00 pm ET

Click here to register.

Top
Facebook
Twitter
Instagram
Website






This email was sent to <<Email Address>>
why did I get this?    unsubscribe from this list    update subscription preferences
Thunder Bay District Health Unit · 999 Balmoral Street · Thunder Bay, On P7B 6E7 · Canada